Safety, Ethics and Regulations

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Pham, Phuc Van (Επιμελητής έκδοσης), Rosemann, Achim (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
• Σειρά: Stem Cells in Clinical Applications,
• Θέματα: Life sciences.; Bioethics.; Medical ethics.; Stem cells.; Regenerative medicine.; Tissue engineering.; Life Sciences.; Stem Cells.; Regenerative Medicine/Tissue Engineering.; Theory of Medicine/Bioethics.

This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, intern...

Πίνακας περιεχομένων:

• Part  I. Safety
• Chapter 1: The safety of allogeneic stem cell transplantation
• Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases
• Chapter 3: IClinical safety and applications of stem cell gene therapy
• Chapter 4:  The safety of non-expanded multipotential stromal cell therapies
• Part  II: Ethics and Regulations
• Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies
• Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions
• Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models
• Chapter 8: Travelling cells – Harmonised European Regualtion and the BAMI stem cell trial
• Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines
• Chapter 10: The regulation of clinical stem cell research in China
• Chapter 11: Gov erning Stem Cell Therapies in India
• Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue
• Chapter 13: The regulatory situation for clinical stem cell research in China
• Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China
• Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations.